Insider Trading & Ownership of Rafael Amado

Location: South San Francisco, CA
Summary: The estimated net worth of Rafael Amado is at least $3,020,641 dollars as of 02 Jan 2026. Rafael Amado is the EVP of R&D of Allogene Therapeutics, Inc. and owns shares of Allogene Therapeutics, Inc. (ALLO) stock worth about $1.72M. Rafael Amado is the President, Head of Global Oncology Research and Development of Zai Lab Ltd and owns shares of Zai Lab Ltd (ZLAB) stock worth about $1.3M.
Signature: /s/ Bruce Blefeld, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Rafael Amado files a new Insider Trading report.

Ownership of Rafael Amado

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ALLO	Allogene Therapeutics, Inc.	EVP of R&D	$1,720,353			07 Oct 2022
ZLAB	Zai Lab Ltd	President, Head of Global Oncology Research and Development	$1,300,288	-$779,230	-37%	30 Dec 2025
PSTX	Poseida Therapeutics, Inc.	Director	$0			08 Jan 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.